Dr. Mary Pat Moyer

Class of 2024-25

Founder, CEO, and Chief Science Officer, INCELL Corporation LLC
INCELL Director of Clinical Therapies, Product Development, and Research
Adjunct Professor, University of Texas Health Science at San Antonio

Mary Pat Moyer is a distinguished biomedical scientist, entrepreneur and manager with more than five decades of experience in biomanufacturing clinical and research-use products for regenerative medicine and infectious diseases.

At INCELL Corporation, she leads the development of innovative products, focusing on human cells, tissues, cell culture, human cellular and tissue-based products, and FDA-registered facilities.

Moyer’s notable accomplishments include leading two INCELL-sponsored Investigational New Drug applications for cell therapies to treat amyotrophic lateral sclerosis, showcasing the first-ever successful treatment that improved disease symptoms.

Her expertise spans human cell therapies, infectious diseases, microbiology, virology and cancer disease mechanisms, as well as sponsorship, development, manufacturing, testing, preclinical and clinical studies, and commercialization of new products.

She received her Ph.D. from The University of Texas at Austin.

Moyer is a member of the National Academy of Engineering and a fellow of the American Academy of Microbiology.

Honors include the Ernst & Young Entrepreneur of the Year, the Breaking the Glass Ceiling Award from the American Association of University Women and the Athena International Award for Women in Leadership.

She has authored 15 books or book chapters, more than 220 peer-reviewed articles and 12 Drug and Device Master Files for the Food and Drug Administration, which provide confidential detailed information about the facilities, processes or articles used in the manufacturing of drugs and medical devices; she also holds three patents.

Moyer will collaborate with faculty and students in the College of Medicine.